Bionano Genomics Inc (BNGO) Stock Price, Quote & News

Company Profile

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 858 888 7600

Website: bionano.com

Address:

9540 Towne Centre Drive, Suite 100, San Diego, United States

WallStreetBuyDip Dec. 27 at 6:51 PM

$BNGO Trading at $1.52, bouncing off lows near $1.47. Seems to be hovering around the $1.50 level with average volume around 311,100.

0 · Reply

UnityUrge Dec. 27 at 2:44 PM

$BNGO The setup is defined by credibility, not hype; balance‑sheet optionality should not erode — clear evidence of repeatability would change the narrative. Execution quality is likely to be the main catalyst.

0 · Reply

RatioSectorDriver Dec. 27 at 8:18 AM

$BNGO Markets appear to be rewarding companies that show durable execution rather than rapid narrative shifts. Balance‑sheet flexibility may prove significant. Evidence of repeatability could meaningfully alter perception. Execution quality becomes the defining catalyst from here.

1 · Reply

WallStreetBuyDip Dec. 26 at 11:41 AM

Especially with small caps like $BNGO, I'm very strict and buy only when H% is low. $BNGO is one ticker I've traded over and over again along with other small/mid cap stocks. Will buy again when H% is low for a reversal trade.

0 · Reply

JinUzuki Dec. 25 at 12:24 AM

$BNGO Agreed. But if you ask Erik they’ve all been from a position of great strength… fucking moron

0 · Reply

Riagain74 Dec. 24 at 10:56 PM

$BNGO the rverse splits here have been ridiculous.

0 · Reply

JinUzuki Dec. 24 at 5:51 AM

$BNGO I’m getting that “NEW ALL TIME LOW” kinda feeling…

0 · Reply

Bizingo Dec. 23 at 6:55 PM

$BNGO Price per share is only down 8 thousand dollars since the ath 5 years ago. No biggie. Should make that up in short time.

0 · Reply

MisterNessuno Dec. 22 at 3:56 PM

$BNGO Ready for EOY, Merry Christmas and happy new year all

0 · Reply

jesseochs1 Dec. 22 at 2:36 AM

$BNGO Merry Christmas all! $MSTR These ceo's are strikingly familiar. May This season of Joy find you well and lead you to the understanding of peace. Some take some give. Give all you can but watch closely to these Michael and Eric.

0 · Reply

Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies

Nov 13, 2025, 7:01 PM EST - 6 weeks ago

Bionano Genomics, Inc. (BNGO) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 4:01 PM EST - 6 weeks ago

Bionano Reports Third Quarter 2025 Results and Highlights Recent Business Progress

Nov 6, 2025, 8:00 AM EST - 7 weeks ago

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

Oct 30, 2025, 4:05 PM EDT - 2 months ago

Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025

Oct 7, 2025, 8:00 AM EDT - 2 months ago

Bionano to Participate in the H.C. Wainwright @ Home Event

Sep 18, 2025, 9:59 AM EDT - 3 months ago

Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge

Sep 17, 2025, 5:00 PM EDT - 3 months ago

Bionano Genomics, Inc. Announces Closing of $10 Million Public Oﬀering

Sep 16, 2025, 1:41 PM EDT - 3 months ago

Crude Oil Rises Over 2%; Bionano Genomics Shares Plunge

Sep 16, 2025, 7:00 AM EDT - 3 months ago

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Sep 15, 2025, 7:00 AM EDT - 3 months ago

CMS Posts Preliminary Payment Determination for New Category I CPT Code Covering Use of OGM for Constitutional Genetic Disorders

Aug 25, 2025, 8:00 AM EDT - 4 months ago

Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Aug 15, 2025, 4:37 AM EDT - 4 months ago

Bionano Genomics, Inc. (BNGO) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:01 PM EDT - 4 months ago

Bionano Reports Second Quarter 2025 Results and Highlights Recent Business Progress

Aug 7, 2025, 8:00 AM EDT - 5 months ago

Bionano Announces Publication Showing Utility of Optical Genome Mapping in Clinical Research of Infant & Toddler T-ALL

Aug 6, 2025, 8:00 AM EDT - 5 months ago

Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference

Jul 31, 2025, 4:05 PM EDT - 5 months ago

Bionano to Report Second Quarter 2025 Financial Results and Host a Conference Call Webcast on August 14, 2025

May 19, 2025, 8:00 AM EDT - 7 months ago

Bionano Laboratories Announces a Second Category I CPT Code for OGM Established by the AMA; this one for Use in Whole Genome Analysis for Constitutional Genetic Disorders

May 14, 2025, 7:46 PM EDT - 8 months ago

Bionano Genomics, Inc. (BNGO) Q1 2025 Earnings Call Transcript

May 14, 2025, 4:01 PM EDT - 8 months ago

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

May 13, 2025, 8:00 AM EDT - 8 months ago

Bionano Laboratories Announces Publication of the Largest Study To-Date Evaluating Clinical Utility of Optical Genome Mapping Across Multiple Hematologic Malignancies

May 7, 2025, 4:01 PM EDT - 8 months ago

Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025

May 2, 2025, 9:30 AM EDT - 8 months ago

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers

Apr 23, 2025, 8:00 AM EDT - 8 months ago

Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease

Apr 8, 2025, 8:00 AM EDT - 9 months ago

Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM

Mar 31, 2025, 8:11 PM EDT - 9 months ago

Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:01 PM EDT - 9 months ago

Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025

Mar 24, 2025, 8:00 AM EDT - 9 months ago

Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect

Mar 18, 2025, 8:00 AM EDT - 10 months ago

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting

Mar 14, 2025, 8:00 AM EDT - 10 months ago

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

Mar 13, 2025, 9:00 AM EDT - 10 months ago

Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML

Jan 22, 2025, 4:05 PM EST - 1 year ago

Bionano Announces Effective Date of Reverse Stock Split

Jan 6, 2025, 4:30 PM EST - 1 year ago

Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Jan 3, 2025, 2:34 PM EST - 1 year ago

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Dec 31, 2024, 3:26 PM EST - 1 year ago

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Dec 23, 2024, 8:30 AM EST - 1 year ago

Bionano Announces Publication from Johns Hopkins School of Medicine Showing that OGM Outperformed Multiple Cytogenetic Assays in a Study of Bone and Soft Tissue Tumor Analysis

Nov 13, 2024, 7:11 PM EST - 1 year ago

Bionano Genomics, Inc. (BNGO) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 1 year ago

Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress

Nov 4, 2024, 4:14 AM EST - 1 year ago

Optical Genome Mapping Market to Witness 26.76% CAGR During 2024-2030 - Consumables and Reagents to Register High Growth - Bionano Genomics, Nucleome Informatics, and Praxis Genomics Dominate the Industry

Oct 31, 2024, 4:30 PM EDT - 1 year ago

Bionano Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Oct 31, 2024, 8:10 AM EDT - 1 year ago

Bionano Adjourns Special Meeting of Stockholders to November 27, 2024

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Preliminary 3Q 2024 Revenues and Cash

Aug 13, 2024, 7:23 PM EDT - 1 year ago

Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)

Aug 7, 2024, 7:11 PM EDT - 1 year ago

Bionano Genomics, Inc. (BNGO) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:01 PM EDT - 1 year ago

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress

Jul 31, 2024, 4:01 PM EDT - 1 year ago

Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 8, 2024, 5:25 PM EDT - 1 year ago

Bionano Announces Closing of up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 5, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jul 2, 2024, 8:00 AM EDT - 1 year ago

Scientific Presentations Highlight OGM's Utility for Cancer Research at Joint Annual Meeting for Three Molecular and Cytogenetic Associations

Jun 20, 2024, 8:00 AM EDT - 1 year ago

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

WallStreetBuyDip Dec. 27 at 6:51 PM

$BNGO Trading at $1.52, bouncing off lows near $1.47. Seems to be hovering around the $1.50 level with average volume around 311,100.

0 · Reply

UnityUrge Dec. 27 at 2:44 PM

0 · Reply

RatioSectorDriver Dec. 27 at 8:18 AM

1 · Reply

WallStreetBuyDip Dec. 26 at 11:41 AM

0 · Reply

JinUzuki Dec. 25 at 12:24 AM

$BNGO Agreed. But if you ask Erik they’ve all been from a position of great strength… fucking moron

0 · Reply

Riagain74 Dec. 24 at 10:56 PM

$BNGO the rverse splits here have been ridiculous.

0 · Reply

JinUzuki Dec. 24 at 5:51 AM

$BNGO I’m getting that “NEW ALL TIME LOW” kinda feeling…

0 · Reply

Bizingo Dec. 23 at 6:55 PM

$BNGO Price per share is only down 8 thousand dollars since the ath 5 years ago. No biggie. Should make that up in short time.

0 · Reply

MisterNessuno Dec. 22 at 3:56 PM

$BNGO Ready for EOY, Merry Christmas and happy new year all

0 · Reply

jesseochs1 Dec. 22 at 2:36 AM

0 · Reply

WallStreetBuyDip Dec. 19 at 2:51 PM

0 · Reply

GuruLulu Dec. 16 at 3:56 PM

$TLRY last time I made money with a squeeze was with $OCGN and $BNGO during covid. Would be nice to experience that again

1 · Reply

MisterNessuno Dec. 14 at 1:48 PM

$BNGO Take attention at the EOY

0 · Reply

gello2000 Dec. 14 at 7:17 AM

$BNGO next reverse split incoming. Maybe offering first

0 · Reply

WallStreetBuyDip Dec. 12 at 12:12 PM

0 · Reply

russil Dec. 10 at 4:52 AM

$BNGO .. https://www.youtube.com/watch?v=LOLn_Vtwqd0

0 · Reply

WallStreetBuyDip Dec. 7 at 6:34 AM

0 · Reply

Nikolay27 Dec. 6 at 11:59 PM

$BNGO 2,4$ next week

1 · Reply

Nikolay27 Dec. 6 at 11:59 PM

$BNGO

0 · Reply

Peaceouty Dec. 5 at 11:23 PM

$BNGO Still sticking to the downward trend eh? Greetings from 2020 ✌🏻

1 · Reply

gstock568 Dec. 3 at 5:22 PM

$IXHL This kinda reminds me of $BNGO which ran $0.25 to $15.00+ back in the day.

1 · Reply

MisterNessuno Dec. 3 at 3:49 PM

$BNGO I am in, 5K at 1,69 and will see

0 · Reply

Market Cap	15.47M
Revenue (ttm)	30.78M
Net Income (ttm)	-112.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-363.94%
Debt to Equity Ratio	0.00

Volume	108,400
Avg Vol	268,604
Day's Range	N/A - N/A
Shares Out	10.18M
Stochastic %K	13%
Beta	2.33
Analysts	Strong Sell
Price Target	$7.50